Steven Cohen's TMDX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 192,594 shares of TransMedics Group, Inc. (TMDX) worth $12.79 M, representing 0.01% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in TMDX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2021, adding 322,000 shares. Largest reduction occurred in Q3 2021, reducing 322,000 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's TransMedics Group (TMDX) Holding Value Over Time
Track share changes against reported price movement
Quarterly TransMedics Group (TMDX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +192,594 | New Buy | 192,594 | $66.42 |
| Q3 2023 | -834 | Sold Out | 0 | $0.00 |
| Q2 2023 | -266 | Reduce 24.18% | 834 | $83.99 |
| Q1 2023 | +1,100 | New Buy | 1,100 | $75.73 |
| Q3 2022 | -11,100 | Sold Out | 0 | $0.00 |
| Q2 2022 | +11,100 | New Buy | 11,100 | $31.44 |
| Q3 2021 | -322,000 | Sold Out | 0 | $0.00 |
| Q2 2021 | +322,000 | New Buy | 322,000 | $33.18 |
| Q1 2021 | -89,800 | Sold Out | 0 | $0.00 |
| Q4 2020 | -209 | Reduce 0.23% | 89,800 | $19.90 |
| Q3 2020 | +58,735 | Add 187.81% | 90,009 | $13.78 |
| Q2 2020 | +31,274 | New Buy | 31,274 | $17.91 |
Steven Cohen's TransMedics Group Investment FAQs
Steven Cohen first purchased TransMedics Group, Inc. (TMDX) in Q2 2020, acquiring 31,274 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held TransMedics Group, Inc. (TMDX) for 12 quarters since Q2 2020.
Steven Cohen's largest addition to TransMedics Group, Inc. (TMDX) was in Q2 2021, adding 322,000 shares worth $10.68 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 192,594 shares of TransMedics Group, Inc. (TMDX), valued at approximately $12.79 M.
As of the Q2 2026 filing, TransMedics Group, Inc. (TMDX) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in TransMedics Group, Inc. (TMDX) was 322,000 shares, as reported at the end of Q2 2021.